Ljungman P. 2012. Vaccination of immunocompromised patients . Clin. Microbiol. Infect. 18 ( Suppl 5 ):93–99. 10.1111/j.1469-0691.2012.03971.x [ Cross Ref ]Ljungman P. 2012. Vaccination of immunocompromised patients. Clin Microbiol Infect 18 Suppl 5:93-99....
In humans, ADCC effector function and/or antibody levels have been associated with the outcome of infection, especially in immunocompromised patients and neonates. Reconstitution of this mechanism with appropriate antibodies or cytokines in ... S Kohl - 《Reviews of Infectious Diseases》 被引量: 180...
Strategies for herpes zoster vaccination of immunocompromised patients. of HZ vaccine in healthy adults before its licensure, a series of strategies are proposed for evaluating the live HZ vaccine in immunosuppressed persons. ... JI Cohen - 《Journal of Infectious Diseases》...
The protective immunization rates in response to hepatitis B vaccination in chronic kidney disease (CKD) patients are lower than response rates in the general population because of genetic and CKD-related factors as well as logistic problems with a proper providing of the recommended vaccination schedu...
Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France 2024, Human Vaccines and Immunotherapeutics Estimated quantification of residual volume in vaccines supplies and its impact on the Brazilian health sys...
The live attenuated influenza vaccine should never be used in immunocompromised patients. The Herpes Zoster Vaccine In patients who plan to undergo immunosuppressive therapy, the herpes zoster vaccine may be administered before the usual age (60 years or older)....
These two cases resemble other reported cases of cutaneous BCG infection following routine vaccination in immunocompromised patients. Mycobacterium bovis infection ... JAMD Richard,SGMD Erin,SBMD Miriam,... - 《Pediatric Dermatology》 被引量: 80发表: 2001年 Disseminated Mycobacterium bovis Infection Fro...
Influenza vaccination in immunocompromised patients: efficacy and safety Immunotherapy, 6 (2014), pp. 131-139 CrossrefView in ScopusGoogle Scholar [27] O. Manuel, F. Lopez-Medrano, L. Keiser, T. Welte, J. Carratala, E. Cordero, et al. Influenza and other respiratory virus infections in ...
This conditions are responsible for the fact that an optimal time point for vaccination of transplanted patients remains not clearly defined. More specific studies about the underlying immunological mechanisms during immunocompromised periods are necessary to understand better the immunogenicity and security ...
Evison J, Farese S, Seitz M, Uehlinger DE, Furrer H, Muhlemann K: Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis. 2009, 48: 1402-1412. 10.1086/598193. Article CAS PubMed Google Scholar Brydak LB, Ros...